Quinoxalines, processes for their preparation and their use

US6369057B1 · kind B1 · utility

Assignee

• Aventis Pharma Deutschland GmbH · DE

Inventors

• Uta-Maria Billhardt · Kronberg, DE
• Manfred Rosner · Eppstein, DE
• Gunther Riess · Frankfurt am Main, DE
• Irvin Winkler · Liederbach, DE
• Rudolf Bender · Kronberg, DE

Key dates

• Filing date: Apr 7, 1995
• Grant date: Apr 9, 2002
• Expiry date: Apr 7, 2015

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D487/04
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

Compounds of the formula I or Ia in which n and the substituents R1, R5 and x have the meaning mentioned have an antiviral activity.